Bacteria - derived short chain fatty acids restore sympathoadrenal responsiveness to hypoglycemia after antibiotic-induced gut microbiota depletionOriginal paper
What was studied?
This study examined whether the gut microbiome, and specifically its short-chain fatty acid (SCFA) byproducts, are needed for a normal sympathoadrenal stress response to hypoglycemia. Researchers depleted the gut microbiota of adult mice with broad-spectrum, non-absorbable antibiotics and then tested their epinephrine response to insulin-induced low blood sugar. They also tested whether simply recolonizing the gut with bacteria, without restoring SCFA production, could reverse any deficits.
Who was studied?
The subjects were male C57Bl6 mice, divided into groups given either regular drinking water (controls) or a cocktail of non-absorbable broad-spectrum antibiotics (Abx) in their drinking water for two weeks. Mice from each group were then injected with either insulin, to induce hypoglycemia, or saline. A separate recolonization group (Abx plus R) was also included to assess reversal of antibiotic effects.
What were the most important findings?
Antibiotic treatment sharply reduced microbial diversity and depleted Bacteroidetes and Firmicutes, enlarged the caecum, and eliminated detectable short-chain fatty acids such as acetate, propionate, and butyrate. These Abx mice showed blunted tonic and stress-induced epinephrine levels. Recolonization restored bacterial diversity but did not restore sympathoadrenal responsiveness or caecal SCFA levels, indicating that bacterial presence alone is insufficient.
What are the greatest implications of this study?
The findings suggest that bacterial metabolites, particularly SCFAs, rather than the mere presence of gut bacteria, are what drive normal adrenal catecholamine responses to hypoglycemia. This points to SCFA restoration, not just microbial recolonization, as the relevant target for repairing stress-response deficits after antibiotic-induced dysbiosis. It also implies that antibiotic courses could carry a previously underappreciated risk of disrupting glucose counter-regulatory physiology.